Ausgabe 3/2014
Inhalt (13 Artikel)
Recovery of myofilament function through reactivation of glycogen synthase kinase 3β (GSK-3β): mechanism for cardiac resynchronization therapy
Syed Raza Shah, Kaneez Fatima, Mehreen Ansari
Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study
Sarah Zaman, Gopal Sivagangabalan, William Chik, Wayne Stafford, John Hayes, Russell Denman, Glenn Young, Prashanthan Sanders, Pramesh Kovoor
Implantable cardioverter defibrillator remote monitoring is well accepted and easy to use during long-term follow-up
Loredana Morichelli, Antonio Porfili, Laura Quarta, Anna Sassi, Renato Pietro Ricci
Influence of QRS duration on outcome of death or appropriate defibrillator therapy by strategy of left ventricular lead placement in cardiac resynchronization therapy recipients
Samir Saba, Josef Marek, Mian Bilal Alam, Evan Adelstein, David Schwartzman, Sandeep Jain, John Gorcsan
Longitudinal follow-up of Riata leads reveals high annual incidence of new conductor externalization and electrical failure
Christian Steinberg, Jean-François Sarrazin, François Philippon, Jean Champagne, Marc-André Bouchard, Franck Molin, Isabelle Nault, Louis Blier, Gilles O’Hara
Paced QRS axis as a predictor of pacing-induced left ventricular dysfunction
Sung-Hwan Kim, Yong-Seog Oh, Gi-Byoung Nam, Kee-Joon Choi, Jae Seok Park, Sang Weon Park, Seung-Jung Park, Young Keun On, June Soo Kim, Woo-Seung Shin, Ji-Hoon Kim, Sung-Won Jang, Man Young Lee, You-Ho Kim, Tai-Ho Rho
A comparison of bleeding complications between warfarin, dabigatran, and rivaroxaban in patients undergoing cryoballoon ablation
David Snipelisky, Jordan C. Ray, Ryan Ung, Melissa Duart, Christine Kauffman, Fred Kusumoto
The benefit of tissue contact monitoring with an electrical coupling index during ablation of typical atrial flutter—a prospective randomised control trial
Michael A. Jones, David Webster, Kelvin C.K. Wong, Christopher Hayes, Norman Qureshi, Kim Rajappan, Yaver Bashir, Timothy R. Betts
Electrophysiological study 6 months after Epicor™ high-intensity focused ultrasound atrial fibrillation ablation
Rodrigue Garcia, Frédéric Sacher, Pierre Oses, Nicolas Derval, Laurent Barandon, Arnaud Denis, Mélèze Hocini, Xavier Roques, Michel Haïssaguerre, Louis Labrousse, Pierre Jaïs
Impact of baseline atrial fibrillation cycle length on acute and long-term outcome of persistent atrial fibrillation ablation
S. Ammar, G. Hessling, M. Paulik, T. Reents, R. Dillier, A. Buiatti, V. Semmler, C. Kolb, B. Haller, I. Deisenhofer
Fluoroscopy-free recrossing of the interatrial septum during left atrial ablation procedures
Nikola Pavlović, Tobias Reichlin, Michael Kühne, Sven Knecht, Stefan Osswald, Christian Sticherling
Catheter ablation versus anti-arrhythmic drug therapy for the management of a trial fibrillation: a meta-analysis
Xiaofeng Cheng, Xiaoqing Li, Yun He, Xiaoyan Liu, Guoqiang Wang, Li Cheng, Jianbo Hu
Transseptal access in pediatric and congenital electrophysiology procedures: defining risk
Johannes C. von Alvensleben, Macdonald Dick II, David J. Bradley, Martin J. LaPage